Exelixis
EXEL
#1760
Rank
โ‚ฌ9.69 B
Marketcap
36,01ย โ‚ฌ
Share price
-0.71%
Change (1 day)
8.08%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company